The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Contemporary considerations in left main stem treatment

EuroIntervention 2017;13:1144-1147. DOI: 10.4244/EIJV13I10A179

Department of Cardiovascular Sciences, University of Leicester, Leicester Biomedical Research Centre, University of Leicester NHS Trust, Leicester, United Kingdom

Percutaneous interventional treatment for disease affecting the left main stem has historically been considered problematic for a number of reasons. Firstly its site, at the origin of the coronary tree, means that any percutaneous therapy has to be absolutely robust. A post-procedural occlusion of a mid or distal circumflex or right coronary artery, while less than ideal, carries far less risk than occlusive stent thrombosis affecting the left main stem. Only recently has stenting become predictably safe through advances in techniques, devices and adjunctive pharmacology. Secondly, left main stem disease is heterogeneous. Treating ostial/shaft disease is very different ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
PCR London Valves 2017: setting the standard in valvular heart disease treatment

Latest news